Literature DB >> 7170269

The effects of amiodarone on thyroid function.

N S Jaggarao, J Sheldon, E N Grundy, R Vincent, D A Chamberlain.   

Abstract

The effects of amiodarone on thyroid function tests in 100 patients treated for 6 weeks to 8 years are reported. One patient became thyrotoxic and 10 developed latent or overt hypothyroidism. Twenty-five patients remained clinically euthyroid throughout, but had free thyroxine indices above the normal range. In these patients with apparently anomalous results, total tri-iodothyronine was normal in 19 cases and low in 1; conversely, free thyroxine was high in all 17 cases in which it was measured. Thyrotrophin releasing hormone (TRH) tests were abnormal in 4 of the 13 patients who had the test. Reverse tri-iodothyronine was significantly raised after 2 weeks amiodarone in 5 healthy subjects, but an equivalent amount of iodine in 9 healthy individuals did not significantly affect any of these tests. We believe that these changes are due in part to inhibition of peripheral conversion of thyroxine to tri-iodothyronine with diversion to reversed tri-iodothyronine. Thyroid function tests should be checked once or twice a year in all patients on maintenance amiodarone. Tests indicating hypothyroidism are likely to be clinically relevant, whereas levels of thyroxine suggesting thyrotoxicosis may be misleading and do not usually imply the need to discontinue treatment with the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7170269      PMCID: PMC2426565          DOI: 10.1136/pgmj.58.685.693

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  16 in total

1.  The radioimmunoassay of thyroxine in unextracted human serum.

Authors:  W A Ratcliffe; J G Ratcliffe; A D McBride; W A Harland; T W Randall
Journal:  Clin Endocrinol (Oxf)       Date:  1974-10       Impact factor: 3.478

2.  Cornea verticillata.

Authors:  J François
Journal:  Doc Ophthalmol       Date:  1969       Impact factor: 2.379

3.  Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents.

Authors:  H Bürgi; C Wimpfheimer; A Burger; W Zaunbauer; H Rösler; T Lemarchand-Béraud
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

4.  Effects of amiodarone on thyroid function in patients with ischaemic heart disease.

Authors:  D A Pritchard; B N Singh; P J Hurley
Journal:  Br Heart J       Date:  1975-08

5.  Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).

Authors:  I J Chopra; D E Williams; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

6.  Iodine-induced thyrotoxicosis in apparently normal thyroid glands.

Authors:  J C Savoie; J P Massin; P Thomopoulos; F Leger
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

7.  Clinical efficacy of amiodarone as an antiarrhythmic agent.

Authors:  M B Rosenbaum; P A Chiale; M S Halpern; G J Nau; J Przybylski; R J Levi; J O Lázzari; M V Elizari
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

8.  Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.

Authors:  A Burger; D Dinichert; P Nicod; M Jenny; T Lemarchand-Béraud; M B Vallotton
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

Review 9.  Iodide goiter and the pharmacologic effects of excess iodide.

Authors:  J Wolff
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

10.  Inhibition of hepatic binding of thyroxine by cholecystographic agents.

Authors:  J V Felicetta; W L Green; W B Nelp
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

View more
  7 in total

1.  Effect of amiodarone on serum T4 and T3 levels in hyperthyroid patients treated with methimazole.

Authors:  O Van Reeth; C Decoster; J Unger
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Renal elimination of amiodarone and its desethyl metabolite.

Authors:  L Harris; C R Hind; W J McKenna; C Savage; S J Krikler; G C Storey; D W Holt
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 4.  Amiodarone: the experience of the past decade.

Authors:  W J McKenna; E Rowland; D M Krikler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

5.  Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination.

Authors:  A Mancini; L De Marinis; F Calabrò; R Sciuto; A Oradei; S Lippa; S Sandric; G P Littarru; A Barbarino
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

6.  Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy.

Authors:  F Bogazzi; L Bartalena; L Tomisti; E Dell'Unto; C Cosci; C Sardella; M L Tanda; A Lai; M Gasperi; F Aghini-Lombardi; E Martino
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

7.  Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.

Authors:  M Stäubli; H Studer
Journal:  Klin Wochenschr       Date:  1985-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.